Prevalence and Risk of Immunostimulatory Herbal Supplement Treatment Among Autoimmune Dermatology Patients
Herbal supplement treatment is prevalent among patients with autoimmune skin diseases, with immunostimulatory supplements posing a significant risk for immune dysregulation, particularly in DM. Providers should proactively screen and counsel patients regarding treatment with these supplements.
Authors
- Laís Lopes Almeida Gomes (ORCID: https://orcid.org/0000-0001-5396-4362)
- D Faden (ORCID: https://orcid.org/0000-0002-2712-9352)
- Victoria P. Werth (ORCID: https://orcid.org/0000-0003-3030-5369)
- Caroline J. Stone (ORCID: https://orcid.org/0000-0002-1697-1659)
- Lillian Xie (ORCID: https://orcid.org/0009-0006-2163-5170)
Institutions
- Philadelphia VA Medical Center (US)
- University of Pennsylvania (US)
Publication Details
- Journal
- ACR Open Rheumatology
- Published
- 2024-09-04
- DOI
- https://doi.org/10.1002/acr2.11735
- Citations
- 3
- Primary Topic
- Dermatology and Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 1.60
Funders
- U.S. Department of Veterans Affairs
- Office of Research and Development
- Lupus Research Alliance
- National Institutes of Health